NIM
ARCT icon

NEOS Investment Management’s Arcturus Therapeutics ARCT Stock Holding History

NEOS Investment Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,481
Closed -$568K – 590
2024
Q3 		$568K Buy
24,481
+1,881
+8% +$40.2K 0.02% 473
2024
Q2 		$550K Buy
22,600
+4,900
+28% +$149K 0.02% 429
2024
Q1 		$598K Buy
17,700
+9,037
+104% +$320K 0.04% 345
2023
Q4 		$273K Buy
+8,663
New +$206K 0.03% 416

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NEOS Investment Management's ARCT Position: Q4 2024 in Review

NEOS Investment Management sold out of Arcturus Therapeutics (ARCT) in Q4 2024, closing a stake of 24,481 shares — an estimated $568K sold.

NEOS Investment Management first reported a position in ARCT in Q4 2023 and held it in 4 quarters. The position peaked at $598K in Q1 2024. 147 funds tracked by Wall St. Rank hold ARCT as of Q4 2024.

  • NEOS Investment Management reported no remaining Arcturus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • NEOS Investment Management sold 24,481 Arcturus Therapeutics shares in Q4 2024, an estimated $568K.
  • NEOS Investment Management first reported a position in Arcturus Therapeutics in Q4 2023 and held it in 4 quarters.
  • NEOS Investment Management's Arcturus Therapeutics position peaked at $598K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2024.

Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.